Caris Life Sciences (CAI) closed at $35.45 on October 28, 2026, up 5.3% from the previous close, on volume of 3,947,131 shares (30-day average 4,233,977).
Data as of October 28, 2026.
28-Oct-2026
PRNewswire (Mon, 19-Oct 6:31 AM ET)
Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026
PRNewswire (Thu, 15-Oct 8:31 AM ET)
Market Chameleon (Wed, 14-Oct 7:51 AM ET)
PRNewswire (Wed, 14-Oct 8:31 AM ET)
PRNewswire (Tue, 8-Sep 6:30 AM ET)
PRNewswire (Wed, 2-Sep 8:31 AM ET)
PRNewswire (Thu, 27-Aug 8:31 AM ET)
Market Chameleon (Thu, 6-Aug 7:20 AM ET)
PRNewswire (Wed, 5-Aug 4:05 PM ET)
Market Chameleon (Mon, 22-Dec 6:59 AM ET)
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
Caris Life Sciences trades on the NASDAQ stock market under the symbol CAI.
As of October 28, 2026, CAI stock price climbed to $35.45 with 3,947,131 million shares trading.
CAI has a beta of 1.96, meaning it tends to be more sensitive to market movements. CAI has a correlation of 0.12 to the broad based SPY ETF.
CAI has a market cap of $10.02 billion. This is considered a Large Cap stock.
Last quarter Caris Life Sciences reported $264 million in Revenue and $.00 earnings per share. This beat revenue expectation by $27 million and missed earnings estimates by -$.01.
The top ETF exchange traded funds that CAI belongs to (by Net Assets): VTI, VB, VBK, VXF, IBB.
CAI has outperformed the market in the last year with a price return of +17.2% while the SPY ETF gained +13.8%. CAI has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +126.8% and +20.0%, respectively, while the SPY returned +4.8% and -0.7%, respectively.
CAI support price is $32.00 and resistance is $35.34 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CAI shares will trade within this expected range on the day.
